138 related articles for article (PubMed ID: 1372325)
1. Studies of V beta 8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis.
Stevens DB; Karpus WJ; Gould KE; Swanborg RH
J Neuroimmunol; 1992 Mar; 37(1-2):123-9. PubMed ID: 1372325
[TBL] [Abstract][Full Text] [Related]
2. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
3. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE.
Birnbaum G; Kotilinek L; Schlievert P; Clark HB; Trotter J; Horvath E; Gao E; Cox M; Braun PE
J Neurosci Res; 1996 May; 44(4):381-96. PubMed ID: 8739158
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor peptide therapy for autoimmune encephalomyelitis: stronger immunization is necessary for effective vaccination.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Cell Immunol; 1994 Feb; 153(2):468-78. PubMed ID: 8118876
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
6. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
7. Two-step activation of T cells, clonal expansion and subsequent Th1 cytokine production, is essential for the development of clinical autoimmune encephalomyelitis.
Jee Y; Matsumoto Y
Eur J Immunol; 2001 Jun; 31(6):1800-12. PubMed ID: 11385625
[TBL] [Abstract][Full Text] [Related]
8. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
Jagessar SA; Heijmans N; Blezer EL; Bauer J; Weissert R; 't Hart BA
J Neuroinflammation; 2015 Sep; 12():169. PubMed ID: 26377397
[TBL] [Abstract][Full Text] [Related]
9. Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity.
Conant SB; Swanborg RH
J Immunol; 2004 May; 172(9):5322-8. PubMed ID: 15100271
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
Khoury SJ; Gallon L; Chen W; Betres K; Russell ME; Hancock WW; Carpenter CB; Sayegh MH; Weiner HL
J Exp Med; 1995 Aug; 182(2):357-66. PubMed ID: 7543136
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-V beta 8.2 chain.
Hashim GA; Offner H; Wang RY; Shukla K; Carvalho E; Morrison WJ; Vandenbark AA
J Immunol; 1992 Oct; 149(8):2803-9. PubMed ID: 1401912
[TBL] [Abstract][Full Text] [Related]
12. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
Waxman FJ; Taguiam JM; Whitacre CC
Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
[TBL] [Abstract][Full Text] [Related]
13. Increased severity of experimental autoimmune encephalomyelitis in rats tolerized as adults but not neonatally to a protective TCR V beta 8 CDR2 idiotope.
Offner H; Malotky MK; Pope L; Vainiene M; Celnik B; Miller SD; Vandenbark AA
J Immunol; 1995 Jan; 154(2):928-35. PubMed ID: 7529291
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
Englert D; Hempel K
Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis.
Offner H; Hashim GA; Vandenbark AA
Science; 1991 Jan; 251(4992):430-2. PubMed ID: 1989076
[TBL] [Abstract][Full Text] [Related]
16. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide.
Buenafe AC; Vainiene M; Celnik B; Vandenbark AA; Offner H
J Immunol; 1995 Aug; 155(3):1556-64. PubMed ID: 7636217
[TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
18. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.
Hempel K; Freitag A; Freitag B; Endres B; Mai B; Liebaldt G
Int Arch Allergy Appl Immunol; 1985; 76(3):193-9. PubMed ID: 2579028
[TBL] [Abstract][Full Text] [Related]
19. Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the Lewis rat V beta 8.2 sequence include CDR2 and framework 3 idiotopes.
Vainiene M; Celnik B; Vandenbark AA; Hashim GA; Offner H
J Neurosci Res; 1996 Jan; 43(2):137-45. PubMed ID: 8820962
[TBL] [Abstract][Full Text] [Related]
20. Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis.
Lenz DC; Wolf NA; Swanborg RH
J Immunol; 1999 Aug; 163(4):1763-8. PubMed ID: 10438907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
